Open AccessMidostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation
Author(s) -
Aleksander SalomonPerzyński,
Urszula Walczak,
Kinga Kos-Zakrzewska,
Ewa LechMarańda,
Bożena Katarzyna Budziszewska
Publication year - 2022
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2720-1015
DOI - 10.5603/hcp.2022.0006
Subject(s) - midostaurin , medicine , oncology , npm1 , myeloid leukemia , tyrosine kinase , fms like tyrosine kinase 3 , hematopoietic stem cell transplantation , cancer research , tyrosine kinase inhibitor , mutation , leukemia , immunology , transplantation , cancer , biology , gene , genetics , receptor , karyotype , chromosome
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom